magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/nccn_ipi",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/nccn_ipi",
"tags": [
"nccn-ipi",
"lymphoma",
"hematology",
"dlbcl",
"prognosis"
],
"mimeType": "application/json",
"description": "Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"age": 40,
"ecog": 0,
"ldh_uln_ratio": 0.9,
"stage_iii_or_iv": false,
"extranodal_major": false
}
},
"output": {
"type": "json",
"example": {
"ecog": 0,
"score": 0,
"formula": "nccn_ipi",
"citation": {
"id": "zhou-2014",
"doi": "10.1182/blood-2013-09-524108",
"pmid": "24264230",
"title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era",
"source": "Blood. 2014;123(6):837-842",
"authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN"
},
"age_years": 40,
"max_score": 8,
"components": [
{
"value": 40,
"factor": "age",
"points": 0,
"present": false
},
{
"value": 0.9,
"factor": "ldh_uln_ratio",
"points": 0,
"present": false
},
{
"factor": "stage_iii_or_iv",
"points": 0,
"present": false
},
{
"factor": "extranodal_major",
"points": 0,
"present": false
},
{
"value": 0,
"factor": "ecog_ge_2",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"ldh_uln_ratio": 0.9,
"nccn_ipi_risk": "low",
"extranodal_major": false,
"formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8"
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"age",
"ecog",
"ldh_uln_ratio",
"stage_iii_or_iv",
"extranodal_major"
],
"properties": {
"age": {
"type": "integer",
"description": "Age in years (18-120). ≤40 scores 0; 41–60 scores 1; 61–75 scores 2; ≥76 scores 3 (Zhou 2014 NCCN-IPI refined age). Age 40 scores 0; 41 and 60 score 1; 61 and 75 score 2; 76 scores 3. Not Shipp IPI binary >60."
},
"ecog": {
"type": "integer",
"description": "ECOG performance status 0-4 as assigned by the caller (Zhou 2014 NCCN-IPI). ≥2 scores 1. magent does not assign ECOG."
},
"ldh_uln_ratio": {
"type": "number",
"description": "Serum LDH divided by the laboratory ULN (0.1-20). ≤1 scores 0; >1 and ≤3 scores 1; >3 scores 2 (Zhou 2014 NCCN-IPI). 1.0 scores 0; 1.01 and 3.0 score 1; 3.01 scores 2. magent does not assay LDH."
},
"stage_iii_or_iv": {
"type": "boolean",
"description": "Ann Arbor stage III or IV as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. magent does not stage lymphoma."
},
"extranodal_major": {
"type": "boolean",
"description": "Extranodal involvement of major organs (bone marrow, CNS, liver/GI tract, or lung) as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. This is not IPI extranodal sites >1. magent does not image extranodal sites."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/nccn_ipi",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"age": 40,
"ecog": 0,
"ldh_uln_ratio": 0.9,
"stage_iii_or_iv": false,
"extranodal_major": false
},
{
"age": 40,
"ecog": 0,
"ldh_uln_ratio": 0.9,
"stage_iii_or_iv": false,
"extranodal_major": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/nccn_ipi",
"count": 2,
"items": [
{
"ecog": 0,
"score": 0,
"formula": "nccn_ipi",
"citation": {
"id": "zhou-2014",
"doi": "10.1182/blood-2013-09-524108",
"pmid": "24264230",
"title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era",
"source": "Blood. 2014;123(6):837-842",
"authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN"
},
"age_years": 40,
"max_score": 8,
"components": [
{
"value": 40,
"factor": "age",
"points": 0,
"present": false
},
{
"value": 0.9,
"factor": "ldh_uln_ratio",
"points": 0,
"present": false
},
{
"factor": "stage_iii_or_iv",
"points": 0,
"present": false
},
{
"factor": "extranodal_major",
"points": 0,
"present": false
},
{
"value": 0,
"factor": "ecog_ge_2",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"ldh_uln_ratio": 0.9,
"nccn_ipi_risk": "low",
"extranodal_major": false,
"formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8"
},
{
"ecog": 0,
"score": 0,
"formula": "nccn_ipi",
"citation": {
"id": "zhou-2014",
"doi": "10.1182/blood-2013-09-524108",
"pmid": "24264230",
"title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era",
"source": "Blood. 2014;123(6):837-842",
"authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN"
},
"age_years": 40,
"max_score": 8,
"components": [
{
"value": 40,
"factor": "age",
"points": 0,
"present": false
},
{
"value": 0.9,
"factor": "ldh_uln_ratio",
"points": 0,
"present": false
},
{
"factor": "stage_iii_or_iv",
"points": 0,
"present": false
},
{
"factor": "extranodal_major",
"points": 0,
"present": false
},
{
"value": 0,
"factor": "ecog_ge_2",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"ldh_uln_ratio": 0.9,
"nccn_ipi_risk": "low",
"extranodal_major": false,
"formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8"
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"age",
"ecog",
"ldh_uln_ratio",
"stage_iii_or_iv",
"extranodal_major"
],
"properties": {
"age": {
"type": "integer",
"description": "Age in years (18-120). ≤40 scores 0; 41–60 scores 1; 61–75 scores 2; ≥76 scores 3 (Zhou 2014 NCCN-IPI refined age). Age 40 scores 0; 41 and 60 score 1; 61 and 75 score 2; 76 scores 3. Not Shipp IPI binary >60."
},
"ecog": {
"type": "integer",
"description": "ECOG performance status 0-4 as assigned by the caller (Zhou 2014 NCCN-IPI). ≥2 scores 1. magent does not assign ECOG."
},
"ldh_uln_ratio": {
"type": "number",
"description": "Serum LDH divided by the laboratory ULN (0.1-20). ≤1 scores 0; >1 and ≤3 scores 1; >3 scores 2 (Zhou 2014 NCCN-IPI). 1.0 scores 0; 1.01 and 3.0 score 1; 3.01 scores 2. magent does not assay LDH."
},
"stage_iii_or_iv": {
"type": "boolean",
"description": "Ann Arbor stage III or IV as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. magent does not stage lymphoma."
},
"extranodal_major": {
"type": "boolean",
"description": "Extranodal involvement of major organs (bone marrow, CNS, liver/GI tract, or lung) as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. This is not IPI extranodal sites >1. magent does not image extranodal sites."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-08-31 13:39Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-13 06:45Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 0
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 13 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/nccn_ipi, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.